Journal of Cancer Research and Clinical Oncology

, Volume 132, Issue 8, pp 487–497

The effects of short-chain fatty acids on colon epithelial proliferation and survival depend on the cellular phenotype

  • Mònica Comalada
  • Elvira Bailón
  • Oscar de Haro
  • Federico Lara-Villoslada
  • Jordi Xaus
  • Antonio Zarzuelo
  • Julio Gálvez
Original Paper

Abstract

Purpose: The short-chain fatty acids (SCFA) are produced via anaerobic bacterial fermentation of dietary fiber within the colonic lumen. Among them, butyrate is thought to protect against colon carcinogenesis. However, few studies analyze the effects of butyrate, and other SCFA, on normal epithelial cells and on epithelial regeneration during disease recovery. Since there are controversial in vitro studies, we have explored the effects of SCFA on different biological processes. Methods: We used both tumoral (HT-29) and normal (FHC) epithelial cells at different phenotypic states. In addition, we analyzed the in vivo activity of soluble dietary fiber and SCFA production in the proliferation rate and regeneration of intestinal epithelial cells. Results: The effect of butyrate on epithelial cells depends on the phenotypic cellular state. Thus, in nondifferentiated, high proliferative adenocarcinoma cells, butyrate significantly inhibited proliferation while increased differentiation and apoptosis, whereas other SCFA studied did not. However, in normal cells or in differentiated cultures as well as in in vivo studies, the normal proliferation and regeneration of damaged epithelium is not affected by butyrate or SCFA exposure. Conclusion: Although butyrate could exert antiproliferative effects in tumor progression, its production is safe and without consequences for the normal epithelium growth.

Keywords

Tumor cells Colorectal cancer Fiber Fermentation Colonic damage 

References

  1. Andoh A, Kinoshita K, Rosenberg I, Podolsky DK (2001) Intestinal trefoil factor induces decay-accelerating factor expression and enhances the protective activities against complement activation in intestinal epithelial cells. J Immunol 167:3887–3893PubMedGoogle Scholar
  2. Araki Y, Andoh A, Fujiyama Y, Itoh A, Bamba T (2002) In vitro alterations in fecal short chain fatty acids and organic anions induced by the destruction of intestinal microflora under hypotonic and aerobic conditions. Int J Mol Med 9:627–631PubMedGoogle Scholar
  3. Augeron C, Laboisse CL (1984) Emergence of permanently differentiated cell clones in a human colonic cancer cell line in culture after treatment with sodium butyrate. Cancer Res 44:3961–3969PubMedGoogle Scholar
  4. Bell CJ, Gall DG, Wallace JL (1995) Disruption of colonic electrolyte transport in experimental colitis. Am J Physiol 268:G622–G630PubMedGoogle Scholar
  5. Breuer RI, Buto SK, Christ ML, Bean J, Vernia P, Paoluzi P, Di Paolo MC, Caprilli R (1991) Rectal irrigation with short-chain fatty acids for distal ulcerative colitis. Preliminary report. Dig Dis Sci 36:185–187PubMedCrossRefGoogle Scholar
  6. Butzner JD, Parmar R, Bell CJ, Dalal V (1996) Butyrate enema therapy stimulates mucosal repair in experimental colitis in the rat. Gut 38:568–573PubMedCrossRefGoogle Scholar
  7. Chantret I, Barbat A, Dussaulx E, Brattain MG, Zweibaum A (1988) Epithelial polarity, villin expression, and enterocytic differentiation of cultured human colon carcinoma cells: a survey of twenty cell lines. Cancer Res 48:1936–1942PubMedGoogle Scholar
  8. Cherbut C, Michel C, Lecannu G (2003) The prebiotic characteristics of fructooligosaccharides are necessary for reduction of TNBS-induced colitis in rats. J Nutr 133:21–27PubMedGoogle Scholar
  9. Comalada M, Camuesco D, Sierra S, Ballester I, Xaus J, Galvez J, Zarzuelo A (2005) In vivo quercitrin anti-inflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-κB pathway. Eur J Immunol 35:584–592PubMedCrossRefGoogle Scholar
  10. D’Argenio G, Mazzacca G (1999) Short-chain fatty acid in the human colon. Relation to inflammatory bowel diseases and colon cancer. Adv Exp Med Biol 472:149–158PubMedGoogle Scholar
  11. D’Argenio G, Cosenza V, Sorrentini I, De Ritis F, Gatto A, Delle Cave M, D’Armiento FP, Mazzacca G (1994) Butyrate, mesalamine, and factor XIII in experimental colitis in the rat: effects on transglutaminase activity. Gastroenterology 106:399–404PubMedGoogle Scholar
  12. Darzynkiewicz Z, Traganos F, Xue SB, Melamed MR (1981) Effect of n-butyrate on cell cycle progression and in situ chromatin structure of L1210 cells. Exp Cell Res 136:279–293PubMedCrossRefGoogle Scholar
  13. Edwards C (1994) The nutritional impact of the intestinal microflora. S Afr Med J Suppl:38S–39SGoogle Scholar
  14. El-Deiry WS, Tokino T, Waldman T, Oliner JD, Velculescu VE, Burrell M, Hill DE, Healy E, Rees JL, Hamilton SR et al (1995) Topological control of p21Waf1/Cip1 expression in normal and neoplastic tissues. Cancer Res 55:2910–2919PubMedGoogle Scholar
  15. Foss FM, Veillette A, Sartor O, Rosen N, Bolen JB (1989) Alterations in the expression of pp60c-src and p56lck associated with butyrate-induced differentiation of human colon carcinoma cells. Oncogene Res 5:13–23PubMedGoogle Scholar
  16. Furrie E, Macfarlane S, Kennedy A, Cummings JH, Walsh SV, O’neil DA, Macfarlane GT (2005) Synbiotic therapy (Bifidobacterium longum/synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial. Gut 54:242–249PubMedCrossRefGoogle Scholar
  17. Graz CJ, Cowley HM (1997) Energy state in HT-29 cells is linked to differentiation. In Vitro Cell Dev Biol Anim 33:277–281PubMedCrossRefGoogle Scholar
  18. Gryfe R, Swallow C, Bapat B, Redston M, Gallinger S, Couture J (1997) Molecular biology of colorectal cancer. Curr Probl Cancer 21:233–300PubMedCrossRefGoogle Scholar
  19. Harig JM, Soergel KH, Komorowski RA, Wood CM (1989) Treatment of diversion colitis with short-chain-fatty acid irrigation. N Engl J Med 320:23–28PubMedCrossRefGoogle Scholar
  20. Hill MJ (1995) Bacterial fermentation of complex carbohydrate in the human colon. Eur J Cancer Prev 4:353–358PubMedCrossRefGoogle Scholar
  21. Hinnebusch BF, Meng S, Wu JT, Archer SY, Hodin RA (2002) The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation. J Nutr 132:1012–1017PubMedGoogle Scholar
  22. Ioachim EE, Katsanos KH, Michael MC, Tsianos EV, Agnantis NJ (2004) Immunohistochemical expression of cyclin D1, cyclin E, p21/waf1 and p27/kip1 in inflammatory bowel disease: correlation with other cell-cycle-related proteins (Rb, p53, ki-67 and PCNA) and clinicopathological features. Int J Colorectal Dis 19:325–333PubMedCrossRefGoogle Scholar
  23. Jacobs LR (1987) Effect of dietary fiber on colonic cell proliferation and its relationship to colon carcinogenesis. Prev Med 16:566–571PubMedCrossRefGoogle Scholar
  24. Kagnoff MF, Eckmann L (1997) Epithelial cells as sensors for microbial infections. J Clin Invest 100:6–10PubMedCrossRefGoogle Scholar
  25. Kalina U, Koyama N, Hosoda T, Nuernberger H, Sato K, Hoelzer D, Herweck F, Manigold T, Singer MV, Rossol S, Bocker U (2002) Enhanced production of IL-18 in butyrate-treated intestinal epithelium by stimulating of the proximal promoter region. Eur J Immunol 32:2635–2643PubMedCrossRefGoogle Scholar
  26. Kaur P, Potten CS (1986) Cell migration velocities in the crypts of the small intestine after cytotoxic insult are not dependent on mitotic activity. Cell Tissue Kinet 19:601–610PubMedGoogle Scholar
  27. Mandal M, Olson DJ, Sharma T, Vadlamudi RK, Kumar R (2001) Butyric acid induces apoptosis by up-regulating Bax expression via stimulation of the c-Jun N-terminal kinase/activation protein-1 pathway in human colon cancer cells. Gastroenterology 120:71–78PubMedCrossRefGoogle Scholar
  28. Marchetti C, Migliorati G, Moraca R, Riccardi C, Nicoletti I, Fabiani R, Mastrandrea V, Morozzi G (1997) Deoxycholic acid and SCFA-induced apoptosis in the human tumor cell-line HT-29 and possible mechanisms. Cancer Lett 114:97–99PubMedCrossRefGoogle Scholar
  29. McIntyre A, Gibson PR, Young GP (1993) Butyrate production from dietary fibre and protection against large bowel cancer in a rat model. Gut 34:386–391PubMedCrossRefGoogle Scholar
  30. Medina V, Afonso JJ, Alvarez-Arguelles H, Hernandez C, Gonzalez F (1998) Sodium butyrate inhibits carcinoma development in a 1,2-dimethylhydrazine-induced rat colon cancer. JPEN J Parenter Enteral Nutr 22:14–17PubMedCrossRefGoogle Scholar
  31. Merritt AJ, Potten CS, Watson AJ, Loh DY, Nakayama K, Nakayama K, Hickman JA (1995) Differential expression of bcl-2 in intestinal epithelia. Correlation with attenuation of apoptosis in colonic crypts and the incidence of colonic neoplasia. J Cell Sci 108:2261–2271PubMedGoogle Scholar
  32. Merritt AJ, Allen TD, Potten CS, Hickman JA (1997) Apoptosis in small intestinal epithelial from p53-null mice: evidence for a delayed, p53-independent G2/M-associated cell death after gamma-irradiation. Oncogene 14:2759–2766PubMedCrossRefGoogle Scholar
  33. Milovic V, Teller IC, Turchanowa L, Caspary WF, Stein J (2000) Effect of structural analogues of propionate and butyrate on colon cancer cell growth. Int J Colorectal Dis 15:264–270PubMedCrossRefGoogle Scholar
  34. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL (1989) Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 96:795–803PubMedGoogle Scholar
  35. Parker SL, Tong T, Bolden S, Wingo PA (1996) Cancer statistics, 1996. CA Cancer J Clin 46:5–27PubMedCrossRefGoogle Scholar
  36. Potten CS (1995) Structure, function and proliferative organization of the mammalian gut. In: Potten CS, Hendry JH (eds) Radiation and gut. Elsevier, New YorkGoogle Scholar
  37. Potter JD (1996) Nutrition and colorectal cancer. Cancer Causes Control 7:127–146PubMedCrossRefGoogle Scholar
  38. Rodriguez-Cabezas ME, Galvez J, Lorente MD, Concha A, Camuesco D, Azzouz S, Osuna A, Redondo L, Zarzuelo A (2002) Dietary fiber down-regulates colonic TNFα and nitric oxide production in the trinitrobenzenesulfonic acid-induced colitic rats. J Nutr 132:3263–3271PubMedGoogle Scholar
  39. Roediger WE (1980) Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut 21:793–798PubMedCrossRefGoogle Scholar
  40. Rombeau JL, Kripke SA (1990) Metabolic and intestinal effects of short-chain fatty acids. JPEN J Parenter Enteral Nutr 14:181S–185SPubMedCrossRefGoogle Scholar
  41. Ruemmele FM, Dionne S, Qureshi I, Sarma DS, Levy E, Seidman EG (1999) Butyrate mediates Caco-2 cell apoptosis via up-regulation of pro-apoptotic BAK and inducing caspase-3 mediated cleavage of poly-(ADP-ribose)polymerase (PARP). Cell Death Differ 6:729–735PubMedCrossRefGoogle Scholar
  42. Sanchez de Medina F, Galvez J, Romero JA, Zarzuelo A (1996) Effect of quercitrin on acute and chronic experimental colitis in the rat. J Pharmacol Exp Ther 278:771–779Google Scholar
  43. Scheppach W, Sommer H, Kirchner T, Paganelli GM, Bartram P, Christl S, Richter F, Dusel G, Kasper H (1992) Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterology 103:51–56PubMedGoogle Scholar
  44. Senagore AJ, MacKeigan JM, Scheider M, Ebrom JS (1992) Short-chain fatty acid enemas: a cost-effective alternative in the treatment of nonspecific proctosigmoiditis. Dis Colon Rectum 35:923–927PubMedCrossRefGoogle Scholar
  45. Siavoshian S, Blottiere HM, Cherbut C, Galmiche JP (1997a) Butyrate stimulates cyclin D and p21 and inhibits cyclin-dependent kinase 2 expression in HT-29 colonic epithelial cells. Biochem Biophys Res Commun 232:169–172CrossRefGoogle Scholar
  46. Siavoshian S, Blottiere HM, Le Foll E, Kaeffer B, Cherbut C, Galmiche JP (1997b) Comparison of the effect of different short chain fatty acids on the growth and differentiation of human colonic carcinoma cell lines in vitro. Cell Biol Int 21:281–287CrossRefGoogle Scholar
  47. Souleimani A, Asselin C (1993) Regulation of c-myc expression by sodium butyrate in the colon carcinoma cell line Caco-2. FEBS Lett 326:45–50PubMedCrossRefGoogle Scholar
  48. Tokumasa A, Katsuno T, Tanaga TS, Yokote K, Saito Y, Suzuki Y (2004) Reduction of Smad3 accelerates re-epithelialization in a murine model of colitis. Biochem Biophys Res Commun 317:377–383PubMedCrossRefGoogle Scholar
  49. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL (1988) Genetic alterations during colorectal-tumor development. N Engl J Med 319:525–532PubMedCrossRefGoogle Scholar
  50. Waseem NH, Lane DP (1990) Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA). Structural conservation and the detection of a nucleolar form. J Cell Sci 96:121–129PubMedGoogle Scholar
  51. Weiss TS, Herfarth H, Obermeier F, Ouart J, Vogl D, Scholmerich J, Jauch KW, Rogler G (2004) Intracellular polyamine levels of intestinal epithelial cells in inflammatory bowel disease. Inflamm Bowel Dis 10:529–535PubMedCrossRefGoogle Scholar
  52. Whitehead RH, Young GP, Bhathal PS (1986) Effects of short chain fatty acids on a new human colon carcinoma cell line (LIM 1215). Gut 27:1457–1463PubMedCrossRefGoogle Scholar
  53. Whitlock JP Jr, Augustine R, Schulman H (1980) Calcium-dependent phosphorylation of histone H3 in butyrate-treated HeLa cells. Nature 287:74–76PubMedCrossRefGoogle Scholar
  54. Xaus J, Comalada M, Cardo M, Valledor AF, Celada A (2001) Decorin inhibits macrophage colony-stimulating factor proliferation of macrophages and enhances cell survival through induction of p27Kip1 and p21Waf1. Blood 98:2124–2133PubMedCrossRefGoogle Scholar
  55. Young GP, McIntyre A, Albert V, Folino M, Muir JG, Gibson PR (1996) Wheat bran suppresses potato starch-potentiated colorectal tumorigenesis at the aberrant crypt stage in a rat model. Gastroenterology 110:508–514PubMedCrossRefGoogle Scholar
  56. Zhang ZH, Ouyang Q, Gan HT (2004) Targeting cyclooxygenase-2 with sodium butyrate and NSAIDs on colorectal adenoma/carcinoma cells. World J Gastroenterol 10:2954–2957PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • Mònica Comalada
    • 1
  • Elvira Bailón
    • 1
  • Oscar de Haro
    • 1
  • Federico Lara-Villoslada
    • 2
  • Jordi Xaus
    • 2
  • Antonio Zarzuelo
    • 1
  • Julio Gálvez
    • 1
  1. 1.Department of Pharmacology, School of PharmacyUniversity of GranadaGranadaSpain
  2. 2.Department of Immunology and Animal SciencesPuleva Biotech, S.A.GranadaSpain

Personalised recommendations